Skip to main content

Table 5 HPV Types detected in patient samples by sequencing using consensus primers GP5+/GP6+

From: Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients

Case #

HPV type

1

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

2

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

3

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

4

7,13,16,18,39,40,43,59,61,68,70,77,91,97

5

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

6

7,13,16,18,39,40,43,59,68,70,77,91,97

8

7,13,16,18,29,39,40,43,45,59,61,68,70,77,85,91,97

9

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

11

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

12

16,18,39,40,43,45,59,61,68,70,77,85,91,97

13

7,13,16,18,39,40,43,45,59,61,68,70,74,85,91,97

14

16,18,29,39,40,43,45,59,68,70,85,91,97

15

7,13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

16

7,13,16,18,39,40,43,45,59,61,68,70,74,77,85,91,97

17

7,13,16,18,29,39,40,43,45,59,61,68,70,77,85,91,97

18

7,16,18,39,40,61,70,77,85,91,97

19

16,18,39,40,43,45,61,70,77,85,91,97

21

7,13,16,40,45,70,77,85

22

7,13,16,39,43,45,70,85

23

7,13,43,45,70,77,85

24

7,43,45,85

25

13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

26

13,16,18,39,40,43,45,59,61,68,70,77,85,91,97

27

1,3,7,11,13,16,18,39,40,43,45,59,61,68,70,77,85,89,91,97

28

29,43,45,59,85

29

45,59,68,70,85

30

1,3,7,11,13,16,18,39,40,43,45,59,61,68,70,77,85,89,91,97

31

16,18,43,45,59,68,70

32

16,18,43,45,59,61,68,70

33

1,13,16,18,39,40,43,44,45,55,59,61,68

34

7,13,16,18,39,43,45,59,61,68,97

35

7,16,18,39,40,43,45,59,61,68,74

36

16,18,39,45,59,61,68,77,97

37

7,13,16,18,39,43,45,59,61,68,77,97

38

7,13,16,18,39,40,43,44,45,55,59,68,74,77,97

39

7,18,39,40,43,59,61,68,74,77,91,97

  1. HPV types identified in patient samples by sequencing with the consensus primer GP5+/GP6+. The most commonly identified HPV type in both OSSN and pterygium tissues included the high risk HPV-18, 16, 45, 39, 59, and 68.